<DOC>
	<DOCNO>NCT00987545</DOCNO>
	<brief_summary>This 2-part study . In first part ( Part I , 8 subject ) , biopsy obtain resection site keloid shave two week follow resection ass select biomarkers determine biologic effect occur shave keloid . No drug administer . In Part II ( 32 patient ) randomize receive QAX576 placebo . An initial drug infusion follow shave removal keloid 6 - 8 day later follow two additional drug infusion 4 week apart . Two week follow resection , punch biopsy perform assess biomarker response . Patients followed-up 52 week first drug administration ass keloid recurrence ( clinically 3D image ) , physician 's patient 's cosmetic assessment , safety .</brief_summary>
	<brief_title>Efficacy 2 Part Study Identification Keloid Biomarkers Effect QAX576 Keloid Recurrence</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<criteria>Patients two keloid trunk , upper extremity thigh . The keloid must meet specified size criterion present great equal 1 year , stable size symptom least 6 month . Use investigational drug time enrollment , history hypersensitivity study drug drug similar chemical class ( e.g . lidocaine , epinephrine , topical antibiotic bacitracin neomycin ) . History repeat recurrence keloid prior surgical removal ( 45 time remove ) . Keloids near hand , joint , anogenital area recurrence might cause significant problem . Any surgical medical condition might significantly alter absorption , distribution , metabolism , excretion drug , may jeopardize patient case participation study Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Keloids</keyword>
	<keyword>recurrence</keyword>
</DOC>